Pembrolizumab for recurrent/metastatic cutaneous squamous cell carcinoma (cSCC): Efficacy and safety results from the phase II KEYNOTE-629 study

被引：0
|
作者：
Grob, J. J. [1 ]
Gonzalez Mendoza, R. [2 ]
Basset-Seguin, N. [3 ]
Vornicova, O. [4 ]
Schachter, J. [5 ]
Joshi, A. [6 ]
Meyer, N. [7 ]
Grange, F. [8 ]
Piulats, J. M. [9 ]
Bauman, J. [10 ]
Zhang, P. [11 ]
Gumuscu, B. [11 ]
Swaby, R. F. [11 ]
Hughes, B. G. M. [12 ]
机构：
[1] AIX Marseille Univ, Dermatol, Marseille, France
[2] Ctr Estatal Cancerol Chihuahua, Surg Oncol, Chihuahua, Mexico
[3] Hop St Louis, Dermatol, Paris, France
[4] Rambam Hlth Care Campus, Oncol, Haifa, Israel
[5] Sheba Med Ctr Tel Hashomer, Div Oncol, Ramat Gan, Israel
[6] Townsville Canc Ctr, Med Oncol, Townsville, Qld, Australia
[7] IUCT Oncopole, Med Oncol, Toulouse, France
[8] Hop Robert Debre, CHU Reims, Dermatol Oncol, Reims, France
[9] Hosp Duran & Reinals ICO Hospitalet, Genitourinary Melanoma & Sarcoma Unit, Med Oncol, Barcelona, Spain
[10] Fox Chase Canc Ctr, Hematol Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[11] Merck & Co Inc, Med Oncol, Kenilworth, NJ USA
[12] Univ Queensland, Royal Brisbane & Womens Hosp, Oncol, Brisbane, Qld, Australia
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA72
引用
收藏
页码：908 / 908
页数：1
相关论文
共 50 条
  • [1] Pembrolizumab in patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC): The phase II KEYNOTE-629 study
    Licitra, L. F.
    Siu, L. L.
    Cohen, E. E. W.
    Zhang, P.
    Gumuscu, B.
    Swaby, R.
    Harrington, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] KEYNOTE-629: Phase 2 trial of pembrolizumab in patients (pts) with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC)
    Licitra, L.
    Siu, L.
    Cohen, E.
    Zhang, P.
    Gumuscu, B.
    Swaby, R.
    Harrington, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] KEYNOTE-629: Phase 2 study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma (cSCC).
    Grob, Jean Jacques
    Gonzalez, Rene
    Basset-Seguin, Nicole
    Schachter, Jacob
    Vornicova, Olga
    Bauman, Jessica Ruth
    Grange, Florent
    Meyer, Nicolas
    Piulats, Josep M.
    Zhang, Eric
    Gumuscu, Burak
    Swaby, Ramona F.
    Hughes, Brett Gordon Maxwell
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] KEYNOTE-629: Phase II study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma
    Grob, Jean-Jacques
    Gonzalez Mendoza, Rene
    Basset-Seguin, Nicole
    Schachter, Jacob
    Vornicova, Olga
    Bauman, Jessica
    Grange, Florent
    Meyer, Nicolas
    Piulats, Josep
    Zhang, Pingye
    Gumuscu, Burak
    Swaby, Ramona
    Hughes, Brett G. M.
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)
    Grob, Jean-Jacques
    Gonzalez, Rene
    Basset-Seguin, Nicole
    Vornicova, Olga
    Schachter, Jacob
    Joshi, Abhishek
    Meyer, Nicolas
    Grange, Florent
    Piulats, Josep M.
    Bauman, Jessica R.
    Zhang, Pingye
    Gumuscu, Burak
    Swaby, Ramona F.
    Hughes, Brett G. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (25) : 2916 - +
  • [6] Pembrolizumab (pembro) for locally advanced (LA) or recurrent/metastatic (R/M) cutaneous squamous cell carcinoma (cSCC): Long-term results of the phase 2 KEYNOTE-629 study
    Couselo, Eva Munoz
    Hughes, Brett Gordon Maxwell
    Mortier, Laurent
    Grob, Jean-Jacques
    Gutzmer, Ralf
    Roshdy, Osama
    Mendoza, Rene Lazaro Gonzalez
    Schachter, Jacob
    Arance, Ana Maria
    Grange, Florent
    Meyer, Nicolas
    Joshi, Abhishek Jagdish
    Billan, Salem
    Ojavee, Sven Erik
    Yuan, Jianda
    Gumuscu, Burak
    Bratland, Ase
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Health-Related Quality of Life of Pembrolizumab for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma in KEYNOTE-629
    Hughes, B. G. M.
    Mendoza Gonzalez, R.
    Basset-Seguin, N.
    Vornicova, O.
    Schachter, J.
    Joshi, A.
    Meyer, N.
    Grange, F.
    Piulats, J. M.
    Bauman, J.
    Chirovsky, D.
    Zhang, P.
    Gumuscu, B.
    Swaby, R.
    Grob, J. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1131 - 1132
  • [8] Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial
    Hughes, B. G. M.
    Munoz-Couselo, E.
    Mortier, L.
    Bratland, A.
    Gutzmer, R.
    Roshdy, O.
    Mendoza, R. Gonzalez
    Schachter, J.
    Arance, A.
    Grange, F.
    Meyer, N.
    Joshi, A.
    Billan, S.
    Zhang, P.
    Gumuscu, B.
    Swaby, R. F.
    Grob, J. -j.
    ANNALS OF ONCOLOGY, 2021, 32 (10) : 1276 - 1285
  • [9] KEYNOTE-629: Efficacy of pembrolizumab (Pembro) per immune-related RECIST (irRECIST) in locally advanced (LA) and recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC)
    Munoz Couselo, E.
    Hughes, B. G. M.
    Bratland, A.
    Gutzmer, R.
    Roshdy, O.
    Gonzalez Mendoza, R.
    Schachter, J.
    Arance Fernandez, A. M.
    Grange, F.
    Meyer, N.
    Joshi, A. J.
    Billan, S.
    Grob, J. J.
    Zhang, P.
    Gumuscu, B.
    Swaby, R.
    Mortier, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S1444 - S1445
  • [10] Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629
    Hughes, Brett G. M.
    Gonzalez Mendoza, Rene
    Basset-Seguin, Nicole
    Vornicova, Olga
    Schachter, Jacob
    Joshi, Abhishek
    Meyer, Nicolas
    Grange, Florent
    Piulats, Josep M.
    Bauman, Jessica R.
    Chirovsky, Diana
    Zhang, Pingye
    Gumuscu, Burak
    Swaby, Ramona F.
    Grob, Jean-Jacques
    DERMATOLOGY AND THERAPY, 2021, 11 (05) : 1777 - 1790
12345